Related Experiment Video
Updated: Oct 9, 2025
07:44
Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
7.7K
A Darwinian perspective on tumor immune evasion
Julieann Puleo1, Kornelia Polyak1
1Department of Medical Oncology, Dana-Farber Cancer Institute, Department of Medicine, Harvard Medical School, Boston, MA, USA.
Biochimica Et Biophysica Acta. Reviews on Cancer
|December 21, 2021
Summary
Tumor cells evolve to evade immune destruction, a key step in cancer development. Understanding this immune evasion through a Darwinian lens can improve cancer therapies and overcome resistance.
Area of Science:
- Oncology
- Immunology
- Evolutionary Biology
Background:
- Tumorigenesis involves critical steps where cancer cells evade immune-mediated destruction.
- The immune system acts as a major selective pressure during tumor evolution.
- Understanding immune evasion is crucial for developing effective cancer immunotherapies.
Purpose of the Study:
- To review the stages of an effective anti-tumor immune response.
- To describe how tumorigenesis disrupts these immune response stages.
- To analyze tumor immune evasion and immunotherapy resistance from a Darwinian perspective.
Main Methods:
- Literature review of anti-tumor immunity.
- Analysis of immune evasion mechanisms during tumorigenesis.
- Discussion of therapeutic strategies to restore anti-tumor immunity.
- Darwinian evolutionary analysis of immune and therapeutic evasion.
Main Results:
- Identified key steps in mounting an anti-tumor immune response.
- Detailed how cancer disrupts each step of immune surveillance.
- Outlined therapeutic strategies to counteract tumor immune evasion.
- Provided a Darwinian framework for understanding immune escape and resistance.
Conclusions:
- Viewing tumor immune evasion through a Darwinian lens offers critical insights.
- This perspective aids in understanding primary immune escape and acquired resistance to immunotherapy.
- It informs the development of novel therapeutic strategies to enhance anti-tumor immunity.
Related Concept Videos
01:27Tumor Immunotherapy
723
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
723
02:53Adaptive Mechanisms in Cancer Cells
6.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
02:17The Tumor Microenvironment
6.9K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.9K
02:07Tumor Progression
6.6K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.6K
01:27Cytotoxic T Cells-mediated Immune Response
4.1K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
4.1K
02:40Cancer Stem Cells and Tumor Maintenance
5.1K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.1K